ShockWave Medical, Inc. stock is down -17.95% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
29 Nov 17:02 | 15 Dec, 2023 | 190.00 | 57 | ||
30 Nov 15:05 | 15 Dec, 2023 | 150.00 | 18 | ||
30 Nov 15:46 | 15 Dec, 2023 | 175.00 | 351 | ||
30 Nov 16:43 | 20 Dec, 2024 | 100.00 | 0 | ||
30 Nov 17:18 | 20 Dec, 2024 | 330.00 | 0 | ||
01 Dec 15:58 | 19 Apr, 2024 | 200.00 | 61 | ||
01 Dec 15:58 | 19 Apr, 2024 | 200.00 | 61 | ||
01 Dec 18:12 | 21 Jun, 2024 | 220.00 | 12 | ||
01 Dec 19:28 | 20 Dec, 2024 | 260.00 | 4 | ||
04 Dec 17:37 | 20 Dec, 2024 | 250.00 | 31 |
ShockWave Medical, Inc. engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease.